Online citations, reference lists, and bibliographies.
← Back to Search

Development Of A Non‐toxic And Non‐denaturing Formulation Process For Encapsulation Of SDF‐1&agr; Into PLGA/PEG‐PLGA Nanoparticles To Achieve Sustained Release

Muhammad Haji Mansor, Mathie Najberg, Aurélien Contini, C. Alvarez-Lorenzo, E. Garcion, C. Jérôme, F. Boury
Published 2018 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Graphical abstract Figure. No caption available. ABSTRACT Chemokines are known to stimulate directed migration of cancer cells. Therefore, the strategy involving gradual chemokine release from polymeric vehicles for trapping cancer cells is of interest. In this work, the chemokine stromal cell‐derived factor‐1&agr; (SDF‐1&agr;) was encapsulated into nanoparticles composed of poly‐(lactic‐co‐glycolic acid) (PLGA) and a polyethylene glycol (PEG)‐PLGA co‐polymer to achieve sustained release. SDF‐1&agr;, and lysozyme as a model protein, were firstly precipitated to promote their stability upon encapsulation. A novel phase separation method utilising a non‐toxic solvent in the form of isosorbide dimethyl ether was developed for the individual encapsulation of SDF‐1&agr; and lysozyme precipitates. Uniform nanoparticles of 200–250 nm in size with spherical morphologies were successfully synthesised under mild formulation conditions and conveniently freeze‐dried in the presence of hydroxypropyl‐&bgr;‐cyclodextrin as a stabiliser. The effect of PLGA carboxylic acid terminal capping on protein encapsulation efficiency and release rate was also explored. Following optimisation, sustained release of SDF‐1&agr; was achieved over a period of 72 h. Importantly, the novel encapsulation process was found to induce negligible protein denaturation. The obtained SDF‐1&agr; nanocarriers may be subsequently incorporated within a hydrogel or other scaffolds to establish a chemokine concentration gradient for the trapping of glioblastoma cells.
This paper references
10.1088/1748-6041/5/6/065002
A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
J. Liu (2010)
10.1016/J.EJPB.2006.01.015
Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage.
W. Abdelwahed (2006)
10.1007/3-540-26367-5_1
A
A. Spring (2005)
10.1074/jbc.M605984200
A Role for Protein Misfolding in Immunogenicity of Biopharmaceuticals*
C. Maas (2007)
10.1023/A:1018826103261
Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and In Vitro Cell Uptake
F. De Jaeghere (2004)
10.1016/J.JCIS.2006.08.047
Thermosensitive-polymer-coated magnetic nanoparticles: adsorption and desorption of bovine serum albumin.
N. Shamim (2006)
10.1088/1748-6041/6/6/065006
PLA-based biodegradable and tunable soft elastomers for biomedical applications.
A. Harrane (2011)
Organic solvents as vehicles for precipitating liquid embolics: a comparative angiotoxicity study with superselective injections of swine rete mirabile.
O. Dudeck (2006)
Freeze-drying of nanoparticles: Formulation
W. Abdelwahed (2006)
10.1038/srep20784
Co-delivery of VEGF and bFGF via a PLGA nanoparticle-modified BAM for effective contracture inhibition of regenerated bladder tissue in rabbits
Xincheng Jiang (2016)
10.1016/j.actbio.2016.11.030
Pharmacologically active microcarriers delivering BDNF within a hydrogel: Novel strategy for human bone marrow-derived stem cells neural/neuronal differentiation guidance and therapeutic secretome enhancement.
S. Kandalam (2017)
10.1007/s10072-011-0608-2
Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue
J. Deng (2011)
10.1016/J.CEP.2011.06.008
Optimization of protein encapsulation in PLGA nanoparticles
Tivadar Feczkó (2011)
10.1002/JPS.20243
Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
I. J. Castellanos (2005)
10.1016/J.JCIS.2003.08.072
Stabilization and encapsulation of human immunoglobulin G into biodegradable microspheres.
J. Wang (2004)
10.7150/thno.19403
Locoregional Confinement and Major Clinical Benefit of 188Re-Loaded CXCR4-Targeted Nanocarriers in an Orthotopic Human to Mouse Model of Glioblastoma
Delphine Séhédic (2017)
10.4161/cam.3.3.8260
Functional diversity of SDF-1 splicing variants
M. Janowski (2009)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
杉山 立樹 (2007)
10.1016/J.IJPHARM.2006.09.015
Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Anshu Yang (2007)
10.1016/j.jconrel.2013.04.017
New PLGA-P188-PLGA matrix enhances TGF-β3 release from pharmacologically active microcarriers and promotes chondrogenesis of mesenchymal stem cells.
M. Morille (2013)
ff ect of zeta potential on the properties of nano – drug delivery systems – a review ( Part 2 )
F. Zahir Honary (2013)
10.3389/fcell.2014.00019
Recruitment of bone marrow-derived cells to periodontal tissue defects
Y. Kimura (2014)
10.1208/s12249-009-9362-7
Determination of End Point of Primary Drying in Freeze-Drying Process Control
S. M. Patel (2009)
10.1523/JNEUROSCI.16-22-07240.1996
A Role in Migration for the αvβ1 Integrin Expressed on Oligodendrocyte Precursors
R. Milner (1996)
10.1021/jp303898g
Thermal and solution stability of lysozyme in the presence of sucrose, glucose, and trehalose.
S. James (2012)
10.1016/j.tiv.2017.03.007
Cytotoxicity and genotoxicity of lipid nanocapsules.
G. Le Roux (2017)
10.1016/J.ADDR.2006.09.017
Freeze-drying of nanoparticles: formulation, process and storage considerations.
W. Abdelwahed (2006)
10.1016/J.EJPB.2004.10.006
Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles.
U. Bilati (2005)
10.1111/j.1525-1438.2007.00786.x
Study on CXCR4/SDF-1α axis in lymph node metastasis of cervical squamous cell carcinoma
J-P Zhang (2006)
10.1016/J.BBAGEN.2007.08.017
Multi-block poloxamer surfactants suppress aggregation of denatured proteins.
D. Mustafi (2008)
10.1016/j.nano.2009.02.002
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin.
J. Park (2009)
10.1016/S0168-3659(00)00340-0
Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.
H. Yoo (2001)
10.1016/j.ijpharm.2015.07.043
Sustained release of TGF-β1 from biodegradable microparticles prepared by a new green process in CO2 medium.
Amin Swed (2015)
10.2147/IJN.S3938
Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers
B. Mukherjee (2008)
10.1016/0006-2952(90)90399-6
Surfactant-induced cell toxicity and cell lysis. A study using B16 melanoma cells.
M. Aránzazu Partearroyo (1990)
10.1016/j.msec.2013.02.020
Accelerating protein release from microparticles for regenerative medicine applications
L. White (2013)
10.1023/A:1016121319668
A Novel Phase Inversion-Based Process for the Preparation of Lipid Nanocarriers
B. Heurtault (2004)
10.1016/J.IJPHARM.2004.11.027
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.
R. Mainardes (2005)
10.1172/JCI15994
Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide.
J. Lévesque (2003)
10.1016/S0378-5173(03)00380-6
Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery.
M. Sameti (2003)
10.1186/1477-3155-10-20
Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases
N. Pirooznia (2012)
10.1016/j.jconrel.2012.01.043
PLGA-based nanoparticles: an overview of biomedical applications.
F. Danhier (2012)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1016/J.IJPHARM.2007.08.034
PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency.
Xiangrong Song (2008)
PEGylated insulin in PLGA microparticles
K. D. Hinds (2005)
10.1016/j.ejpb.2010.03.005
Effect of various additives and polymers on lysozyme release from PLGA microspheres prepared by an s/o/w emulsion technique.
A. Paillard-Giteau (2010)
10.1016/S0378-5173(99)00178-7
Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
A. Sánchez (1999)
10.1016/j.ejpb.2012.08.005
Preparation of polymeric particles in CO(2) medium using non-toxic solvents: formulation and comparisons with a phase separation method.
My-Kien Tran (2012)
10.1002/MABI.200500143
Synthesis and rheological properties of polylactide/poly(ethylene glycol) multiblock copolymers.
F. Li (2005)
10.1289/ehp.10727
Compound Cytotoxicity Profiling Using Quantitative High-Throughput Screening
M. Xia (2008)
10.1081/PDT-100102031
Freeze-Drying and Lyopreservation of Diblock and Triblock Poly(Lactic Acid)–Poly(Ethylene Oxide) (PLA–PEO) Copolymer Nanoparticles
F. De Jaeghere (2000)
10.1016/j.ejpb.2008.03.006
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres.
A. Giteau (2008)
Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model
北折 俊之 (2009)
10.1016/S0168-3659(00)00326-6
Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant.
T. Morita (2000)
10.1016/J.EJPS.2004.09.011
Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles.
U. Bilati (2005)
10.1023/B:PHAM.0000029275.41323.a6
Structure-Immunogenicity Relationships of Therapeutic Proteins
Suzanne Hermeling (2004)
10.1007/S10856-007-3010-0
Controlled release of insulin from PLGA nanoparticles embedded within PVA hydrogels
J. Liu (2007)
10.1016/j.ijpharm.2011.03.056
Surfactant dependent toxicity of lipid nanocapsules in HaCaT cells.
Caroline Maupas (2011)
10.1245/s10434-009-0599-x
Hepatic Stellate Cells Promote Liver Metastasis of Colon Cancer Cells by the Action of SDF-1/CXCR4 Axis
R. Matsusue (2009)
10.1227/01.NEU.0000324896.26088.EF
CXCR4 EXPRESSION IS ELEVATED IN GLIOBLASTOMA MULTIFORME AND CORRELATES WITH AN INCREASE IN INTENSITY AND EXTENT OF PERITUMORAL T2‐WEIGHTED MAGNETIC RESONANCE IMAGING SIGNAL ABNORMALITIES
C. Stevenson (2008)
10.1155/2012/896141
Immunosuppressive Activity of Size-Controlled PEG-PLGA Nanoparticles Containing Encapsulated Cyclosporine A
L. Tang (2012)
10.1163/092050611X576648
Biodegradable Nanoparticles for Protein Delivery: Analysis of Preparation Conditions on Particle Morphology and Protein Loading, Activity and Sustained Release Properties
J. Coleman (2012)
10.1016/j.jconrel.2008.09.073
A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles.
Einat Cohen-Sela (2009)
10.1016/j.ijpharm.2014.11.042
Surface coating mediates the toxicity of polymeric nanoparticles towards human-like macrophages.
N. Grabowski (2015)
10.1038/sj.onc.1207097
Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells
M. Burger (2003)
10.1016/j.rinphs.2012.11.001
Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres
Moraima Morales-Cruz (2012)
10.1007/S00396-009-2131-Z
Protein-loaded PLGA–PEO blend nanoparticles: encapsulation, release and degradation characteristics
M. J. Santander-Ortega (2010)
10.1016/J.IJPHARM.2005.10.003
A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
W. Abdelwahed (2006)
10.1016/j.geb.2003.09.006
Preparation
M. Voorneveld (2004)
10.1016/J.JCONREL.2005.02.020
PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.
K. Hinds (2005)
10.3748/wjg.v17.i19.2389
CXCR4/SDF-1 axis is involved in lymph node metastasis of gastric carcinoma.
Bao-cheng Zhao (2011)
10.1002/bit.22690
Collapse temperature of solutions important for lyopreservation of living cells at ambient temperature
G. Yang (2010)
10.1258/ebm.2010.010219
Biocompatibility study of glycofurol in rat brains
A. Boongird (2011)
10.1634/stemcells.2007-0725
Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C‐Terminal Lysine of Stromal Cell‐Derived Factor‐1α: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization?
L. Marquez-Curtis (2008)
10.1182/BLOOD-2003-08-2857
Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity
M. D. L. L. Sierra (2004)
10.4314/TJPR.V12I2.19
Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 2)
S. Honary (2013)



This paper is referenced by
10.33582/2578-8760/1009
Encapsulation of Zn-DTPA into poly lactic-co-glycolic acid nanoparticles via a modified double emulsion method for extended release into lung fluid 1
E. Lai (2018)
10.3390/mi9050243
Nanostructure-Enabled and Macromolecule-Grafted Surfaces for Biomedical Applications
Madeline Small (2018)
10.1016/j.joca.2018.08.021
Mechanisms of endogenous repair failure during intervertebral disc degeneration.
K. Ma (2019)
10.1016/j.psj.2020.08.041
Poloxamer 188 exerts a cryoprotective effect on rooster sperm and allows decreasing glycerol concentration in the freezing extender
M. Mehdipour (2020)
10.1016/j.carbpol.2020.116107
Aerogel sponges of silk fibroin, hyaluronic acid and heparin for soft tissue engineering: Composition-properties relationship.
Mathie Najberg (2020)
10.1007/s40005-019-00442-2
PEGylated polylactide (PLA) and poly (lactic-co-glycolic acid) (PLGA) copolymers for the design of drug delivery systems
D. R. Perinelli (2019)
10.1016/J.APSUSC.2018.04.059
Controllable fabrication of porous PLGA/PCL bilayer membrane for GTR using supercritical carbon dioxide foaming
C. Song (2019)
10.1016/J.JDDST.2018.12.032
Biocompatibility and safety of insulin-loaded chitosan nanoparticles/ PLGA-PEG-PLGA hydrogel (ICNPH) delivered by subconjunctival injection in rats
Xianfang Rong (2019)
10.1007/s00210-020-01825-1
Fluorescent tamoxifen-encapsulated nanocapsules functionalized with folic acid for enhanced drug delivery toward breast cancer cell line MCF-7 and cancer cell imaging
Ehsan Nankali (2020)
10.1016/j.jconrel.2020.04.005
Targeted drug delivery therapies inspired by natural taxes.
H. V. Nguyen (2020)
10.3390/pharmaceutics12040356
Characterization and Mathematical Modeling of Alginate/Chitosan-Based Nanoparticles Releasing the Chemokine CXCL12 to Attract Glioblastoma Cells
Suzanne Gascon (2020)
10.3390/pharmaceutics12060513
Development of a Sustained Release Nano-In-Gel Delivery System for the Chemotactic and Angiogenic Growth Factor Stromal-Derived Factor 1α
J. O’Dwyer (2020)
10.1007/s40204-020-00139-y
Recent advances in the formulation of PLGA microparticles for controlled drug delivery
Elena Lagreca (2020)
10.3389/fphar.2019.00887
Reversing the Tumor Target: Establishment of a Tumor Trap
Mathie Najberg (2019)
10.4155/fmc-2018-0521
Nanoformulations for glioblastoma multiforme: a new hope for treatment.
R. Ortiz (2019)
10.1177/0892705719856052
On briefing the surface modifications of polylactic acid: A scope for betterment of biomedical structures:
Guravtar Singh Mann (2019)
10.1007/s40005-019-00439-x
Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles
Enas M. Elmowafy (2019)
Semantic Scholar Logo Some data provided by SemanticScholar